Generation and characterization of the humoral immune response to DNA immunization with a chimeric β-amyloid-interleukin-4 minigene

European Journal of Immunology

Volumn 33, Issue 12, 2003, Pages 3232-3241

  Ghochikyan, Anahit ^a   Vasilevko, Vitaly ^a   Petrushina, Irina ^b   Movsesyan, Nina ^a   Babikyan, Davit ^a   Tian, Wenqiang ^b   Sadzikava, Nadya ^b   Ross, Ted M ^c   Head, Elizabeth ^b   Cribbs, David H ^b   Agadjanyan, Michael G ^a  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Antibodies; Antigens; DNA immunization; Epitopes; Mice

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; CHIMERIC PROTEIN; DNA VACCINE; EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; INTERLEUKIN 4; MUTANT PROTEIN; PEPTIDE; PLASMID VECTOR; PROTEIN PRECURSOR;

ACTIVE IMMUNIZATION; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; ASTROCYTOSIS; B LYMPHOCYTE; CLEARANCE; CONTROLLED STUDY; DRUG EFFICACY; DYSTROPHY; EPITOPE MAPPING; FEMALE; GENE CONSTRUCT; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; MALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TH2 CELL; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; BIOLISTICS; CHO CELLS; CRICETINAE; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN ISOTYPES; INTERLEUKIN-4; MICE; RECOMBINANT FUSION PROTEINS; VACCINES, DNA;

EID: 10744223260     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324000     Document Type: Article

References (59)

1. Price, D. L. and Sisodia, S. S., Cellular and molecular biology of Alzheimer's disease and animal models. Annu. Rev. Med. 1994. 45: 435-446.
2. Hardy, J. A. and Higgins, G. A., Alzheimer's disease: the amyloid cascade hypothesis. Science 1992. 256: 184-185.
3. Selkoe, D. J., The molecular pathology of Alzheimer's disease. Neuron 1991. 6: 487-498.
4. Esler, W. P. and Wolfe, M. S., A Portrait of alzheimer secretases - new features and familiar faces. Science 2001. 293: 1449-1454.
5. Sisodia, S. S., An accomplice for gamma-secretase brought into focus. Science 2000. 289: 2296-2297.
6. Small, D. H., Mok, S. S. and Bornstein, J. C., Alzheimer's disease and Aβ-toxicity. From top to bottom. Nat. Rev. Neurosci. 2001. 2: 595-598.
7. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D. and Seubert, P., Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999. 400: 173-177.
8. Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C., Gordon, M. and Arendash, G. W., A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000. 408: 982-985.
9. Janus, C., Chishti, M. A. and Westaway, D., Transgenic mouse models of Alzheimer's disease. Biochim. Biophys. Acta 2000. 1502: 63-75.
10. Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B. and Morris, R. G. M., A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000. 408: 975-979.
11. Bard, F., Cannon, C., Barbour, R., Burke, R. L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D. and Yednock, T., Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 2000. 6: 916-919.
12. DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J. C., Paul, S. M. and Holtzman, D. M., Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2001. 98: 8850-8855.
13. Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M. and Paul, S. M., Immunization reverse memory deficits without reducing brain Ab burden in Alzheimer's disease model. Nat. Neurosci. 2002. 5: 452-457.
14. Schenk, D., Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning. Nat. Rev. Neurosci. 2002. 3: 824-828.
15. Birmingham, K. and Frantz, S., Set back Alzheimer vaccine studies. Nat. Med. 2002. 8: 199-200.
16. O'Shea, J. J., Ma, A. and Lipsky, P., Cytokines and autoimmunity. Nat. Rev. Immunol. 2002. 2: 37-45.
17. Town, T., Vendrame, M., Patel, A., Poetter, D., DelleDonne, A., Mori, T., Smeed, R., Crawford, F., Klein, T., Tan, J. and Mullan, M., Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's β-amyloid. J. Neuroimmunol. 2002. 132: 49-59.
18. Weiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Granfell, T. J., Mori, C., Issazadeh, S., Hancock, W. W. and Selkoe, D. J., Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 2000. 48: 567-579.
19. Cribbs, D. H., Ghochikyan, A., Tran, M., Vasilevko, V., Petrushins, I., Sadzikava, N., Kesslak, P., Kieber-Emmons, T., Cotman, C. W. and Agadjanyan, M. G., Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with betaamyloid. Int. Immunol. 2003. 15: 505-514.
20. Ruiz, P. J., Garren, H., Ruiz, I. U., Hirshberg, D. L., Nguyen, L. T., Karpuj, M. V., Cooper, M. T., Mitchell, D. J., Fathman, C. G. and Steinman, L., Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J. Immunol. 1999. 162: 3336-3341.
21. Garren, H., Ruiz, P. J., Watkins, T. A., Fontoura, P., Nguyen, L. T., Estline, E. R., Hirschberg, D. L. and Steinman, L., Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity. 2001. 15: 15-22.
22. Lemere, C. A., Maron, R., Selkoe, D. J. and Weiner, H. L., Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease. DNA Cell Biol. 2001. 20: 705-711.
23. Ertl, H. C. and Xiang, Z. Q., Genetic immunization. Viral Immunol. 1996. 9: 1-9.
24. Kim, J. J., Bagarazzi, M. L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D. M., Ciccarelli, R., Chattergoon, M. A., Dang, K., Mahalingam, S., Chalian, A. A., Agadjanyan, M. G., Boyer, J. D., Wang, B. and Weiner, D. B., Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 1997. 15: 641-646.
25. Agadjanyan, M. G., Trivedi, N. N., Kudchodkar, S., Bennett, M., Levine, W., Lin, A., Boyer, J., Levy, D., Ugen, K. E., Kim, J. J. and Weiner, D. B., An HIV type 2 DNA vaccines induces cross-reactive immune responses against HIV type 2 and SIV. AIDS Res. Hum. Retroviruses 1997. 13: 1561-1572.
26. Agadjanyan, M. G., Ugen, K., Wang, B., Villafana, T., Merva, M., Petrushina, I., Williams, W. W. and Weiner, D. B., DNA inoculation with an HTLV-1 envelope DNA construct elicits immune responses in rabbits. In Chanock, R. M., Ginsberg, H.S., Brown, F. and Lerner, R.A. (Eds.), Vaccines '94: modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1994, pp 47-53.
27. Agadjanyan, M. G., Kim, J. J., Trivedi, N., Wilson, D. M., Monzavi-Karbassi, B., Morrison, L. D., Nottingham, L. K., Dentchev, T., Tsai, A., Dang, K., Chalian, A. A., Maldonado, M. A., Williams, W. V. and Weiner, D. B., CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J. Immunol. 1999. 162: 3417-3427.
28. Ross, T. M., Xu, Y., Bright, R. A. and Robinson, H. L., C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 2000. 1: 127-131.
29. Wang, B., Ugen, K. E., Srikantan, V., Agadjanyan, M. G., Dang, K., Refaeli, Y., Sato, A. I., Boyer, J., Williams, W. V. and Weiner, D. B., Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1993. 90: 4156-4160.
30. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Feigner, P. L., Dwarki, V. J., Gromkowsk, I. S. H., Deck, R. R., DeWitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L. and Liu, M. A., Heterologous; protection against influenza by injection of DNA encoding a viral protein. Science. 1993. 259: 1745-1749.
31. Hoffman, S. L., Doolan, D. L., Sedegah, M., Gramzinski, R., Wang, H., Gowda, K., Hobart, P., Margalith, M., Norman, J. and Hedstrom, R. C., Nucleic acid malaria vaccines. Ann. N. Y. Acad. Sci. 1995. 772: 88-94.
32. Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., Gromkowski, S. H., Singh, M., Lew, D., Yankauckas, M. A., Baird, S. M. and Rhodes, G. H., Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 1994. 91: 9519-9523.
33. Robinson, H. L., Nucleic acid vaccines: an overview. Vaccine 1997. 15: 785-787.
34. Tang, D. C., DeVit, M. and Johnston, S. A., Genetic immunization is a simple method for eliciting an immune response. Nature 1992. 356: 152-154.
35. Kim, J. J., Simbiri, K. A., Sin, J. I., Dang, K., Oh, J., Dentchev, T., Lee, D., Nottingham, L. K., Chalian, A. A., McCallus, D., Ciccarelli, R., Agadjanyan, M. G. and Weiner, D. B., Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. J. Interferon Cytokine Res. 1999. 19: 77-84.
36. Kim, J. J., Trivedi, N. N., Nottingham, L. K., Morrison, L., Tsai, A., Hu, Y., Mahalingam, S., Dang, K., Ahn, L., Doyle, N. K., Wilson, D. W., Chattergoon, M., Chalian, A. A., Boyer, J., Agadjanyan, M. G. and Weiner, D. B., Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 1998. 28: 1089-1103.
37. Chow, Y. H., Chiang, B. L., Lee, Y. L., Chi, W. K., Lin, W. C., Chen, Y. T. and Tho, M. H., Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 1998. 160: 1320-1329.
38. Geissler, M., Gesien, A., Tokushige, K. and Wands, J. R., Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 1997. 158: 1231-1237.
39. Ishii, K. J., Weiss, W. R., Ichino, M., Verthelyi, D. and Klinman, D. M., Activity and safety of DNA plasmids encoding IL-4 and IFN gamma. Gene. Ther 1999. 6: 237-244.
40. Thor, G. and Brian, A. A., Glycosylation variants of murine interleukin-4: evidence for different functional properties. Immunol. 1992. 75: 143-149.
41. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L. and Beyreuther, K., Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. Eur. J. Biochem. 1991. 201: 61-69.
42. Bowers, W. J. and Federoff, H. J., Amyloid immunotherapy-engendered CNS inflammation. Neurobiol. Aging 2002. 23: 663-674.
43. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Felgner, P. L., Direct gene transfer into mouse muscle in vivo. Science. 1990. 247: 1465-1468.
44. Muthumani, K., Kudchodkar, S., Zhang, D., Bagarazzi, M. L., Kim, J. J., Boyer, J. D., Ayyavoo, V., Pavlakis, G. N. and Weiner, D. B., Issues for improving multiplasmid DNA vaccines for HIV-1. Vaccine. 2002. 20: 1999-2003.
45. Kim, J. J., Ayyavoo, V., Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., Boyer, J. D. and Weiner, D. B., In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 1997. 158: 816-826.
46. Berzofsky, J. A., Ahlers, J. D. and Belyakov, I. M., Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 2001. 1: 209-219.
47. Kieber-Emmons, T., Monzavi-Karbassi, B., Wang, B., Luo, P. and Weiner, D. B., Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induces functional anticarbohydrate antibody response. J. Immunol. 2000. 165; 623-627.
48. Doolan, D. L. and Hoffman, S. L., DNA-based vaccines against malaria: status and promise of the multi-stage malaria DNA vaccine operation. Int. J. Parasitol. 2001. 31: 753-762.
49. Parker, S. E., Monteith, D., Horton, H., Hof, R., Hernandez, P., Vilalta, A., Hartikka, J., Hobart, P., Bentley, C. E., Chang, A., Hedstrom, R., Rogers, W. O., Kumar, S., Hoffman, S. L. and Norman, J. A., Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther. 2001. 8: 1011-1023.
50. Green, T. D., Montefiori, D. C. and Ross, T. M., Enhancment of antibodies to the human immunodeficiency virus type I envelope by using the molecular adjuvant C3d. J. Virol. 2003. 77: 2046-2055.
51. Dickey, C. A., Morgan, D. G., Kudchodkar, S., Weiner, O. B., Bai, Y., Cao, C., Gordon, M. N. and Ugen, K. E., Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide. DNA Cell Biol. 2001. 20: 723-729.
52. Town, T., Tan, J., Sansone, N., Obregon, D., Klein, T. and Mullan, M., Characterization of murine immunoglobulin G antibodies against human amyloid-b 1-42. Neurosci. Lett. 2001. 307: 101-104.
53. McLaurin, J., Cecal, R., Kierstead, M. E., Tian, X., Phinney, A. L., Manea, M., French, J. E., Lambermon, M. H., Darabie, A. A., Brown, M. E., Janus, C., Chishti, M. A., Horne, P., Westaway, D., Fraser, P. E., Mount, H. T., Przybylski, M. and St. George-Hyslop, P., Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat. Med 2002. 8: 1263-1269.
54. Bard, F., Barbour, R., Cannon, C., Carretto, R., Fox, M., Games, D., Guido, T., Hoenow, K., Hu, K., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, C., Lee, M., Motter, R., Nguyen, M., Reed, A., Schenk, D., Tang, P., Vasquez, N., Seubert, P. and Yednock, T., Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc. Natl. Acad. Sci. USA. 2003. 100: 2023-2028.
55. Karin, N., Gene therapy for T cell mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccine. Isr. Med. Assoc. J. 2000. 2. 63-68.
56. Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J. F., Beckmann, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mossmann, T. R. and Paul, W. E., Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 1990. 8: 303-333.
57. Petrushina, I., Tran, M., Sadzikava, N., Ghochikyan, A., Vasilevko, V., Agadjanyan, M. G. and Cribbs, D. H., Importance of IgG2c isotype in the immune response to b-amyloid in APP/Tg mice. Neurosci. Left. 2003. 338: 5-8.
58. Solomon, B., Koppel, R., Hanan, E. and Katzav, T., Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc. Natl. Acad. Sci. USA 1996. 93: 452-455.
59. Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H. and Weller, R. O., Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 2003. 9: 448-452.